RGCON 2020 Focussed on Hemato-Oncology Update


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ RGCON 2020
RGCON is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, etc.

RGCON 2020, the 19th Annual International Conference of Rajiv Gandhi Cancer Institute and Research Centre to be held in New Delhi from 7th - 9th February 2020 is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, Sickle Cell Disease, Thalassemia as well as cancers of other organs.

“Renowned national and international experts in the field of Haematology, Hemato-oncology & Stem Cell Transplant have committed their participation to share their views & deliver lectures on the current practices. As a distinctive feature, RGCON 2020 will cover latest updates from American Society of Haematology (ASH) and American Society of Clinical Oncology (ASCO) and various other events,” said Dr. Dinesh Bhurani, Director, Department of Hemato-Oncology & Bone Marrow Transplant, RGCIRC & Organising Secretary – RGCON 2020.

“Over the years, the aim of RGCON has been to bring eminent international and national faculty at one platform to share new advances in oncology and haematology leading to good interaction between faculty and delegates. We are fortunate to have distinguished international and national faculty for RGCON 2020 too,” said Dr. Sudhir Kumar Rawal, Medical Director and Chief of GenitoUro – Oncology Services RGCIRC.

Another unique feature of RGCON 2020 is a get together of Myeloma patients. The First Myeloma patient who got CarT cell treatment from China will also be present & share her experience.

Over the years, Hemato-Oncology has witnessed some path breaking advancements. Blood Cancers are treated with chemotherapy while some require bone marrow transplant. Now Targeted Therapy and Immunotherapy are fast taking the place of chemotherapy in treatment of blood cancers. Under immunotherapy, body’s own T cells are modified to kill cancer cells, added Dr. Bhurani.

Blood cancers account for around 20% of the total cancers in India. Different blood cancers occur at different age groups. Leukaemia occurs in Children while Lymphoma and Myeloma generally occur in old age.

Speaking about causes of blood cancers, Dr. Bhurani stated, blood cancers generally don’t have any direct causal relationship. Blood cancers are due to genetic changes in cells and generally not linked to any preventive causes.

The symptoms of blood cancers include fever and bleeding from any part – nose, mouth etc in case of leukaemia and lumps in neck in case of Lymphoma.

Tags : #Rgcon #Bloodcancer #Stemcell #Transplant #Hematooncology #Medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026